Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors. - Wikidata - wikimedia - TriplyDB

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.

http://www.wikidata.org/entity/Q35382871

about

Increasing the potency and breadth of an HIV antibody by using structure-based rational design Polyclonal B cell responses to conserved neutralization epitopes in a subset of HIV-1-infected individuals The HIV glycan shield as a target for broadly neutralizing antibodies The evolution within us Structural insights on the role of antibodies in HIV-1 vaccine and therapy Designing synthetic vaccines for HIV HIV-1 neutralizing antibodies: understanding nature's pathways Antibodies in HIV-1 vaccine development and therapy HIV-1 antibodies from infection and vaccination: insights for guiding vaccine design Catching HIV 'in the act' with 3D electron microscopy Vaccine-Elicited Tier 2 HIV-1 Neutralizing Antibodies Bind to Quaternary Epitopes Involving Glycan-Deficient Patches Proximal to the CD4 Binding Site Maturation Pathway from Germline to Broad HIV-1 Neutralizer of a CD4-Mimic Antibody Structure of HIV-1 gp120 V1/V2 domain with broadly neutralizing antibody PG9 Co-evolution of a broadly neutralizing HIV-1 antibody and founder virus Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies Structures of HIV-1 Env V1V2 with broadly neutralizing antibodies reveal commonalities that enable vaccine design Complex-type N-glycan recognition by potent broadly neutralizing HIV antibodies Broad and potent neutralization of HIV-1 by a gp41-specific human antibody Vaccine Induction of Antibodies against a Structurally Heterogeneous Site of Immune Pressure within HIV-1 Envelope Protein Variable Regions 1 and 2 Viral Escape from Neutralizing Antibodies in Early Subtype A HIV-1 Infection Drives an Increase in Autologous Neutralization Breadth Broadly Neutralizing Antibody PGT121 Allosterically Modulates CD4 Binding via Recognition of the HIV-1 gp120 V3 Base and Multiple Surrounding Glycans Structural basis for diverse N-glycan recognition by HIV-1–neutralizing V1–V2–directed antibody PG16 The Effects of Somatic Hypermutation on Neutralization and Binding in the PGT121 Family of Broadly Neutralizing HIV Antibodies Functional Implications of the Binding Mode of a Human Conformation-Dependent V2 Monoclonal Antibody against HIV Delineating antibody recognition in polyclonal sera from patterns of HIV-1 isolate neutralization Progress in HIV-1 vaccine development.Antiviral Therapy by HIV-1 Broadly Neutralizing and Inhibitory Antibodies Targeting host-derived glycans on enveloped viruses for antibody-based vaccine design Cell- and Protein-Directed Glycosylation of Native Cleaved HIV-1 Envelope Human antibodies that neutralize HIV-1: identification, structures, and B cell ontogenies Monoclonal antibodies to the V2 domain of MN-rgp120: fine mapping of epitopes and inhibition of α4β7 binding Humanized Immunoglobulin Mice: Models for HIV Vaccine Testing and Studying the Broadly Neutralizing Antibody Problem.Survivors Remorse: antibody-mediated protection against HIV-1.Asymmetric recognition of HIV-1 Envelope trimer by V1V2 loop-targeting antibodies.Recent advances on the use of structural biology for the design of novel envelope immunogens of HIV-1 HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development HIV-1 Glycan Density Drives the Persistence of the Mannose Patch within an Infected Individual.Mechanisms of Adaptive Immunity to Porcine Reproductive and Respiratory Syndrome Virus Induction of Potent and Long-Lived Antibody and Cellular Immune Responses in the Genitorectal Mucosa Could be the Critical Determinant of HIV Vaccine Efficacy.Pentavalent HIV-1 vaccine protects against simian-human immunodeficiency virus challenge.

P2860

Q24631510-566CB5AA-EB4C-4850-A861-5240A7F7A665 Q24635002-A5AB98BF-A02D-4C1D-944A-8711D76BAB91 Q26786540-025F05E2-65EA-46A1-9F6D-2643814A45E7 Q26801603-AB047E02-A5A9-4B73-9153-9CBD87278A31 Q26829461-C6F7175B-6A63-47A5-8E0C-DC4CE67F80DE Q26862617-C38202FD-C250-4524-BD93-71936DABE1AA Q27000480-74207D9B-538B-487E-B4F7-4FA67CFE78E0 Q27011574-512060AC-E55A-4E11-BA62-E945FFCAAC32 Q27022055-0C90A1EC-77C2-4A1F-8122-1682C1F73664 Q27026806-DD1C063E-7E45-4EBA-BA6A-2AA2F44A0C49 Q27319450-1F0AE12D-C414-437C-99A6-B3AE1A089B42 Q27644415-42684967-E44E-4045-8B07-020C51E2B02C Q27644478-B3283335-4C19-494E-8DEC-449E3883E449 Q27644501-6B386496-0183-4227-A663-6875AD120AE9 Q27644515-EFC0F05E-D798-4BBB-9B4F-458BE9A59437 Q27644634-15E10E0B-C8E7-45D5-8BA7-3A95BEE727C8 Q27674878-B3D3674B-6CF8-4F51-8A2E-E04B9A2BE5C4 Q27675131-8AFE7D49-5842-4245-8699-69AE9739011F Q27675879-16ED5EB9-186B-4C75-88DF-397F4A829238 Q27676728-5F94E3BD-8073-40B8-B878-9918762D5C5A Q27678062-46162F27-78C5-4246-9A70-05D4557A121E Q27678312-992A8DDA-5196-4041-BB24-0F69A3F2612A Q27680688-F1EB34E8-86FA-4DD0-9676-8A39310ED143 Q27681527-CDA10702-3394-4B68-BE73-ADE890374582 Q27684578-47E2866B-7EEE-41EE-813C-CD1603446F3D Q27693849-DAC47CA1-426B-4CBB-AED8-0752E097E7B5 Q28066335-60290250-69D7-4209-86C4-B81709442E60 Q28084672-1D19274A-E575-4C45-B4C3-94453B226E21 Q28263655-76194FF8-E301-4A41-A11A-5DC5A760D895 Q28602877-5F05364F-3F4A-4902-8280-8D5734EAB6FC Q28728517-D59C1091-617F-4F60-A8C0-E24A16B4C268 Q30234773-B4E51E39-F8A4-4F0A-B154-4257D28C51EB Q30238730-D42CAEB9-0617-486A-B5F8-AF394A259B5E Q30352300-ADFC3720-96D6-42B0-96F0-27DABDC9DC23 Q30353580-8D501FC6-5741-4F82-B8CF-3020D9CE4F43 Q30355260-09042551-DA5D-4E1B-87C6-FEC56A4099B0 Q30393763-4842D3C7-06EA-4177-8313-B014CFDCF033 Q32183108-D2BB72B3-57EB-490F-B362-B6D8FC7DDDF6 Q33611645-498F07FA-245A-40C2-AE4F-F14C0F634BF4 Q33804531-E0E8ECCA-7975-41A1-AA1D-BDC85362ECAC

P2860

Analysis of a clonal lineage of HIV-1 envelope V2/V3 conformational epitope-specific broadly neutralizing antibodies and their inferred unmutated common ancestors.

http://www.wikidata.org/entity/Q35382871

description

2011 nî lūn-bûn

@nan

2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@ast

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@en

type

label

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@ast

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@en

prefLabel

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@ast

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@en

P1433

Q35382871-28FA1811-7AA9-4290-A32D-97DC18C82723

P1476

Q35382871-C6C199FC-912D-49DC-84AA-5EC8009BF51B

P2093

Q35382871-0240D136-A9A5-4AA0-8805-30F1E3DD9DF0

Q35382871-16F06035-4960-40B2-B0EB-BF891737CFB0

Q35382871-181963F2-CE45-49BB-8176-9773565C05E2

Q35382871-18A01782-EC0B-45DD-9264-76C528636999

Q35382871-28F6AF49-6E6C-407E-A6FE-827A35524357

Q35382871-358DB22C-0152-4960-AFA7-6483BCC29A9B

Q35382871-3C1A43DE-0E8C-473A-9999-F6ED4804FD67

Q35382871-489F3175-F7E2-453D-B3F1-8B911AF8B9CB

Q35382871-48BBBF7E-CD9D-4E63-8035-F348B4D95C00

Q35382871-538288E1-A43D-461E-9526-FE099E0B7F19

P2860

Q35382871-02E9D4E8-31D3-4543-A87A-9B22E7E0E26C

Q35382871-039D4551-8B7B-4951-AFA0-7AFD34FFE4D0

Q35382871-062376A5-0A41-455F-BECB-8727A9DA8D29

Q35382871-0B9EFE44-2587-431C-87E7-D83CAC5859DE

Q35382871-10A3115C-2070-4A02-967C-B34944145018

Q35382871-137B289D-0824-4EDD-BCC3-4E52331A80F4

Q35382871-162529ED-D67F-4613-8B53-14DF6A640454

Q35382871-1839948E-F345-4BA4-96F1-42D2F34D2F48

Q35382871-195FABDA-9277-4481-8B9B-76BEB3859969

Q35382871-1E2D51AD-E48E-45B0-9A6A-F04DBFAE61EE

P304

Q35382871-006F9830-5D62-4564-A2F8-19C2FDBE5C88

P31

Q35382871-AB017C9A-BFFC-4E73-9E41-9E8DD790DD7F

P356

Q35382871-E49F573F-536E-4D94-B5F1-333D6917AE10

P407

Q35382871-5CBF859A-6603-401C-8F1E-7B538477A0DE

P433

Q35382871-DA7F2F04-9B59-4DC1-AFB6-67AD81FBBC92

P478

Q35382871-CCEDA44B-5CC5-44F9-81F7-5834FA29ECF0

P50

Q35382871-003DB010-283A-4569-B494-2309924DEEF8

Q35382871-1C807CB3-2B24-464C-B01D-CA40B18059F3

Q35382871-23FFF141-4A87-4D70-A18D-0A49CE62A215

Q35382871-3912C520-8F68-4932-A708-8D3A2C991E41

Q35382871-7B5D367A-5A2C-4502-91D4-46FB732CB270

Q35382871-85D17FF2-DDEA-459E-9F39-1A33F7BA570E

Q35382871-89FB5652-EB92-433B-AC61-05ADB6FACB98

Q35382871-BA171F1E-4749-427F-A070-FDCB7238409F

Q35382871-BCC1A0AF-A1B3-4049-8B77-7AB545B05AEA

Q35382871-CB97B471-1D64-4CC8-A394-E6AB7117D404

P577

Q35382871-A0F6F11D-F5B6-47C3-84C2-0ABF7553A9EE

P698

Q35382871-4A171087-0026-41D5-A8A0-8881C8965386

P921

Q35382871-4DB5FB2E-905F-4B61-9605-9646F47636EA

P932

Q35382871-6D7DCE97-7112-46C3-9685-0689F28F463F

P356

P1433

Journal of Virology

P1476

Analysis of a clonal lineage o ...... ed unmutated common ancestors.

@en

P2093

Baoshan Zhang

http://www.w3.org/2001/XMLSchema#string

Chun-Yen Tsao

http://www.w3.org/2001/XMLSchema#string

Dawn J Marshall

http://www.w3.org/2001/XMLSchema#string

Faruk Sinangil

http://www.w3.org/2001/XMLSchema#string

Georgia D Tomaras

http://www.w3.org/2001/XMLSchema#string

Hua-Xin Liao

http://www.w3.org/2001/XMLSchema#string

Jiang Zhu

http://www.w3.org/2001/XMLSchema#string

John A Crump

http://www.w3.org/2001/XMLSchema#string

John F Whitesides

http://www.w3.org/2001/XMLSchema#string

Kwan-Ki Hwang

http://www.w3.org/2001/XMLSchema#string

P2860

Crystal structure of a neutralizing human IGG against HIV-1: a template for vaccine design

Structure and function of broadly reactive antibody PG16 reveal an H3 subdomain that mediates potent neutralization of HIV-1

Crystal Structure of PG16 and Chimeric Dissection with Somatically Related PG9: Structure-Function Analysis of Two Quaternary-Specific Antibodies That Effectively Neutralize HIV-1

Crystal Structure of Human Antibody 2909 Reveals Conserved Features of Quaternary Structure-Specific Antibodies That Potently Neutralize HIV-1

Base-calling of automated sequencer traces using phred. II. Error probabilities

Base-calling of automated sequencer traces using phred. I. Accuracy assessment

Antibody neutralization and escape by HIV-1

Broad and potent neutralizing antibodies from an African donor reveal a new HIV-1 vaccine target

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

Efficient neutralization of primary isolates of HIV-1 by a recombinant human monoclonal antibody

P304

9998-10009

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1128/JVI.05045-11

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

85

http://www.w3.org/2001/XMLSchema#string

P50

Thomas B. Kepler

David C Montefiori

Joseph Sodroski

P577

2011-07-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21795340

http://www.w3.org/2001/XMLSchema#string

P921

P932

3196428

http://www.w3.org/2001/XMLSchema#string